3SBio (HK:1530) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
3SBio’s subsidiary, Zhejiang Sunshine Mandi Pharmaceutical, achieved remarkable success during the 2024 ‘Double 11’ sales campaign. Its Mandi® brand topped multiple online platforms, including Tmall, JD Pharmacy, and TikTok Shop, in various OTC categories. This achievement highlights the brand’s strong market presence and potential growth in the pharmaceutical sector.
For further insights into HK:1530 stock, check out TipRanks’ Stock Analysis page.
